This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of pharmaceutical products. The contract has a ceiling value of $3,914.11 and an ultimate completion date of December 5, 2024. The contract is a firm fixed-price delivery order that is not set aside for any specific business classification.
Dakota Drug, Inc. is also the holder of a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC, part of the DLA Troop Support Medical's ECAT Generation V Program, allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations through December 31, 2025. The current delivery order is one of many that have been awarded to Dakota Drug, Inc. under this IDC for the provision of various medical products, including prescription medications, medical devices, vaccines, and healthcare-related supplies.
Generated 3/5/25, 9:49 AM